Variation in GALNS enzymatic activity has been proposed as a biomarker of MPS IVA: low levels are observed in more severe phenotypes and higher levels in attenuated forms [45,46]. The gene discussed is GALNS; the disease is mucopolysaccharidosis type 4A.